Arcus Biosciences, Inc. RCUS
- AB102 — Atopic Dermatitis Preclinical
- AB102 — Chronic Spontaneous Urticaria Preclinical
MRGPRX2 (2 companies · 4 programs)
Companies with an active program directed at MRGPRX2.
Evommune, Inc. EVMN
- EVO756 — Chronic Inducible Urticaria Phase 2
- EVO756 — Migraine Phase 2